SPOTLIGHT: CDC halts Hib boosters after Merck recall

In the wake of Merck's Hib vaccine recall, the CDC is telling docs to stop giving the booster shot that comes due for infants at 12 to 15 months. Sanofi Pasteur won't be able to make up the shortfall, at least not immediately, officials say; Merck recalled 1.2 million doses and shut down production, with new shipments delayed probably until the fourth quarter of 2008. Report

Suggested Articles

Horizon Therapeutics has notched an FDA approval for its rare eye disease med Tepezza (teprotumumab), a possible blockbuster drug in the making.

Eli Lilly has a pipeline stuffed with a host of assets and has decided it needs a new injectable drug and device plant to manufacture some of them.

After Clovis’ Rubraca snagged an FDA boost in prostate cancer last week, AZ and Merck’s rival Lynparza has matched it with a boost of its own.